Prostate Cancer Survey

Prostate Cancer Clinical Trial

Official title:

Identifying Patient-relevant Adverse Events Following Prostate Radiotherapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03128710
• Other study ID #: HP-00073268
• Status: Completed
• Start date: March 15, 2017
• Est. completion date: February 15, 2018

Study information

• Verified date: November 2020
• Source: University of Maryland, Baltimore
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

There have been calls from patients, payers, healthcare providers, and policy makers for an evaluation of newer, high-cost radiation technologies compared to conventional forms of radiation therapy. National attention has focused on the use of intensity modulated radiation therapy (IMRT) into routine daily clinical practice for prostate cancer. The goal of the present study is to determine whether the type of radiation treatment received by the patients can result in a reduction in patient-relevant side effects following prostate irradiation. The analysis will be performed by obtaining patient answered surveys looking at side effects.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 224
• Est. completion date: February 15, 2018
• Est. primary completion date: February 15, 2018
• Accepts healthy volunteers: No
• Gender: Male
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Participant is 18 years or older

• Has been diagnosed with prostate cancer

• Able to speak and read English

Exclusion Criteria:

• Participant is not being seen for prostate cancer

• Under the age of 18

Related Conditions & MeSH terms

• Prostate Cancer
• Prostatic Neoplasms

Locations

Country	Name	City	State
United States	UMMC	Baltimore	Maryland

Sponsors (1)

Lead Sponsor	Collaborator
University of Maryland, Baltimore

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To determine patient preference weights for side effect reduction in radiation treatment of prostate cancer	Investigators will use an anonymous survey and results from multiple focus groups to quantify the relative importance/significance of commonly encountered side effects experienced by patients following external beam radiation therapy. We will complete descriptive statistics as a means of understanding the data obtained by survey responses. Additionally, comparative analyses may be undertaken to evaluate differences between different side effects experienced.	3 years